Join
Live feed
·
INSIDERFilingvia Quantisnow
Emergent BioSolutions Inc. logo

Director Katkin Keith was granted 25,344 shares and sold $128,183 worth of shares (15,481 units at $8.28) as part of a pre-agreed trading plan, increasing direct ownership by 11% to 96,294 units (SEC Form 4) (withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EBS (Emergent BioSolutions Inc.) and more on Quantisnow.